The current treatment paradigm for patients with advanced laryngeal squamous cell carcinoma continues to evolve. The authors assembled a panel of experts from the fields of medical oncology, radiation oncology, and surgery to discuss treatment options and to defend their positions.
Controversies in the management of retromolar trigone carcinoma
✍ Scribed by Tareck Ayad; Louis Guertin; Denis Soulières; Manon Belair; Stéphane Temam; Phuc Felix Nguyen-Tân
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 108 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Our objective is to discuss the current controversies that surround the management of retromolar trigone (RMT) cancer. We conducted this literature review to discuss trigone cancer. RTM and anterior pillar cancers should be studied separately. Preoperative clinical and radiographic assessments need to be further investigated to establish their reliability at predicting bone invasion. In the absence of suspicion of bone invasion, surgery and radiotherapy seem to give similar results, but recent reports indicate a greater benefit if they are used in combination. Some authors have advocated systematic segmental resection for all RMT cancers but marginal mandibulectomy is a reasonable option in selected cases. Standard treatment for RMT cancers with N0 necks is selective neck dissection or radiation therapy, depending on the modality of treatment of the primary. Allowing a better understanding of the evolution of RMT cancer and its response to different treatment modalities requires efforts to report different institutional experience with this rare tumor. © 2008 Wiley Periodicals, Inc. Head Neck, 2009
📜 SIMILAR VOLUMES
Published data confirm the aggressive clinical behavior of uterine serous carcinoma. More research is needed to determine the optimal postoperative management of women diagnosed with this cancer. See also pages 2214–21.
The 5-year cause specific actuarial survival rate for 178 patients treated for testicular seminoma at The Princess Margaret Hospital 1977 to 1981 is 97%. Controversies exist over how to optimally use and integrate chemotherapy (a) and radiation therapy ( R I ) to minimize morbidity and achieve these